COVID-19

Nafamostat is identified as a potential candidate for COVID-19 patients by scientists at the University of Tokyo and Leibniz…

The stockpile would be funded from a new health budget worth 9.4 billion euros ($10.3 billion) which the EU executive commission…

The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking to recruit around 10,000 adults and children…

AveXis, which makes Novartis’s $2.1 million-per-patient gene therapy Zolgensma for the hereditary disease spinal muscular atrophy,…

It has removed the export restriction on ITC HS code 29222933 of paracetamol API, making it free for export with immediate effect

Over 150 COVID-19 vaccines are currently under development by biopharma companies and research organisations around the world.

This takes total commitment of Ajanta Pharma to Rs crore crore towards fight against COVID 19

The investigators have already performed the in silico work by high-throughput virtual screening approach to examine the binding…

Inspite of COVID-19-linked disruptions, Kamal Karanth, Co-founder, Xpheno, a specialist staffing company believes that the long…

Instructs pharma associations to ensure that member companies follow ethical practices for brand promotion, especially during…